We generated neuroblastoma cell lines expressing this construct and knocked out endogenous KAT2A using CRISPR-Cas9 with an sgRNA that spans an intron/exon junction and therefore cannot cut the exogenous cDNA of KAT2A. This evidence concerns the gene KAT2A and neuroblastoma.